HEADER APOPTOSIS 04-DEC-13 2MHS TITLE NMR STRUCTURE OF HUMAN MCL-1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 171-327; COMPND 6 SYNONYM: BCL-2-LIKE PROTEIN 3, BCL2-L-3, BCL-2-RELATED PROTEIN COMPND 7 EAT/MCL1, MCL1/EAT; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PSR482-21.1 KEYWDS MCL-1, BCL-2 FAMILY, BH DOMAIN, APOPTOSIS, CANCER DRUG, GFT NMR EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR G.LIU,L.POPPE,K.AOKI,H.YAMANE,J.LEWIS,T.SZYPERSKI REVDAT 2 14-JUN-23 2MHS 1 SEQADV REVDAT 1 14-MAY-14 2MHS 0 JRNL AUTH G.LIU,L.POPPE,K.AOKI,H.YAMANE,J.LEWIS,T.SZYPERSKI JRNL TITL HIGH-QUALITY NMR STRUCTURE OF HUMAN ANTI-APOPTOTIC PROTEIN JRNL TITL 2 DOMAIN MCL-1(171-327) FOR CANCER DRUG DESIGN. JRNL REF PLOS ONE V. 9 96521 2014 JRNL REFN ESSN 1932-6203 JRNL PMID 24789074 JRNL DOI 10.1371/JOURNAL.PONE.0096521 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR, CNS REMARK 3 AUTHORS : VARIAN (VNMR), BRUNGER, ADAMS, CLORE, GROS, NILGES REMARK 3 AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MHS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000103631. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 0.3 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.7 MM [U-100% 13C; U-100% 15N] REMARK 210 MCL-1, 95% H2O/5% D2O; 0.7 MM [U- REMARK 210 5% 13C; U-100% 15N] MCL-1, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 15N/13CALIPHATIC/13CAROMATIC REMARK 210 -RESOLVED NOESY; GFT(4,3)D REMARK 210 HNNCABCA; GFT(4,3)DCABCACONHN; REMARK 210 GFT(4,3)D HABCABCONHN; GFT(4,3)D REMARK 210 HNNCO; GFT (4,3)D HCCH; 2D 1H- REMARK 210 13C HSQC; 2D 1H-15N HSQC; 2D 1H- REMARK 210 13C HSQC AROMATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, XEASY, AUTOASSIGN, REMARK 210 AUTOSTRUCTURE, CYANA, CNS, REMARK 210 SPSCAN, PSVS REMARK 210 METHOD USED : DISTANCE GEOMETRY, MOLECULAR REMARK 210 DYNAMICS, SIMULATED ANNEALING, REMARK 210 TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG A 32 -80.43 60.98 REMARK 500 1 LEU A 66 -76.05 -82.20 REMARK 500 1 ASP A 67 91.89 47.21 REMARK 500 1 VAL A 89 -177.54 -62.85 REMARK 500 1 THR A 90 -78.99 -87.00 REMARK 500 1 ASN A 91 89.58 45.41 REMARK 500 1 GLN A 114 45.55 -84.82 REMARK 500 1 HIS A 151 72.48 56.65 REMARK 500 1 VAL A 152 -68.52 -103.16 REMARK 500 1 GLU A 156 -62.64 -105.58 REMARK 500 1 HIS A 160 57.73 -154.16 REMARK 500 2 ALA A 24 -156.62 -140.24 REMARK 500 2 PRO A 29 -77.20 -58.23 REMARK 500 2 MET A 30 -30.75 174.63 REMARK 500 2 LEU A 66 -69.57 -99.94 REMARK 500 2 ASP A 67 -48.63 71.70 REMARK 500 2 ILE A 68 98.24 62.97 REMARK 500 2 THR A 90 20.57 -77.38 REMARK 500 2 ASN A 91 81.00 -68.57 REMARK 500 2 GLN A 114 38.86 -92.74 REMARK 500 2 ARG A 141 80.83 59.84 REMARK 500 2 HIS A 159 -61.70 69.86 REMARK 500 2 HIS A 160 103.86 -44.42 REMARK 500 3 ALA A 24 -159.89 -112.06 REMARK 500 3 ARG A 32 -76.85 -104.87 REMARK 500 3 LEU A 66 -73.66 -118.90 REMARK 500 3 ASP A 67 -43.86 70.45 REMARK 500 3 ILE A 68 90.27 62.83 REMARK 500 3 THR A 90 -62.11 63.58 REMARK 500 3 TRP A 92 11.32 -69.24 REMARK 500 3 ARG A 141 60.16 61.61 REMARK 500 3 HIS A 159 107.64 -42.70 REMARK 500 4 THR A 27 19.96 -148.67 REMARK 500 4 LEU A 66 -76.18 -117.18 REMARK 500 4 ASP A 67 -40.72 71.12 REMARK 500 4 ILE A 68 94.25 60.42 REMARK 500 4 PHE A 85 32.76 -88.57 REMARK 500 4 GLN A 114 36.99 -99.61 REMARK 500 4 ARG A 141 89.71 62.29 REMARK 500 4 GLU A 156 -45.50 -140.31 REMARK 500 5 MET A 30 -83.43 -117.14 REMARK 500 5 ASP A 67 97.71 54.37 REMARK 500 5 THR A 90 86.10 -67.66 REMARK 500 5 GLN A 114 40.84 -91.95 REMARK 500 5 ARG A 141 72.17 51.49 REMARK 500 5 HIS A 151 74.83 65.75 REMARK 500 5 ASP A 154 -164.68 -102.62 REMARK 500 5 GLU A 156 -71.58 -115.99 REMARK 500 5 HIS A 163 12.44 58.00 REMARK 500 6 THR A 27 48.55 -143.27 REMARK 500 REMARK 500 THIS ENTRY HAS 181 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19654 RELATED DB: BMRB DBREF 2MHS A 2 158 UNP Q07820 MCL1_HUMAN 171 327 SEQADV 2MHS MET A 1 UNP Q07820 INITIATING METHIONINE SEQADV 2MHS SER A 117 UNP Q07820 CYS 286 ENGINEERED MUTATION SEQADV 2MHS HIS A 159 UNP Q07820 EXPRESSION TAG SEQADV 2MHS HIS A 160 UNP Q07820 EXPRESSION TAG SEQADV 2MHS HIS A 161 UNP Q07820 EXPRESSION TAG SEQADV 2MHS HIS A 162 UNP Q07820 EXPRESSION TAG SEQADV 2MHS HIS A 163 UNP Q07820 EXPRESSION TAG SEQADV 2MHS HIS A 164 UNP Q07820 EXPRESSION TAG SEQRES 1 A 164 MET GLU ASP GLU LEU TYR ARG GLN SER LEU GLU ILE ILE SEQRES 2 A 164 SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA LYS ASP SEQRES 3 A 164 THR LYS PRO MET GLY ARG SER GLY ALA THR SER ARG LYS SEQRES 4 A 164 ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY VAL GLN SEQRES 5 A 164 ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU ARG LYS SEQRES 6 A 164 LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER LEU SER SEQRES 7 A 164 ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL THR ASN SEQRES 8 A 164 TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY ALA PHE SEQRES 9 A 164 VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SER SER SEQRES 10 A 164 ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL LEU VAL SEQRES 11 A 164 ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG GLY TRP SEQRES 12 A 164 ASP GLY PHE VAL GLU PHE PHE HIS VAL GLU ASP LEU GLU SEQRES 13 A 164 GLY GLY HIS HIS HIS HIS HIS HIS HELIX 1 1 ASP A 3 GLY A 23 1 21 HELIX 2 2 SER A 33 ASP A 67 1 35 HELIX 3 3 ASN A 70 VAL A 84 1 15 HELIX 4 4 ASN A 91 ILE A 112 1 22 HELIX 5 5 GLN A 114 LYS A 133 1 20 HELIX 6 6 LYS A 133 GLN A 140 1 8 HELIX 7 7 ARG A 141 PHE A 150 1 10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1